PROMETHACON Drug Patent Profile
✉ Email this page to a colleague
When do Promethacon patents expire, and what generic alternatives are available?
Promethacon is a drug marketed by Polymedica and is included in two NDAs.
The generic ingredient in PROMETHACON is promethazine hydrochloride. There is one drug master file entry for this compound. Forty-seven suppliers are listed for this compound. Additional details are available on the promethazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Promethacon
A generic version of PROMETHACON was approved as promethazine hydrochloride by ZYDUS PHARMS USA on November 18th, 2005.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for PROMETHACON?
- What are the global sales for PROMETHACON?
- What is Average Wholesale Price for PROMETHACON?
Summary for PROMETHACON
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Raw Ingredient (Bulk) Api Vendors: | 110 |
| Patent Applications: | 2,760 |
| DailyMed Link: | PROMETHACON at DailyMed |
US Patents and Regulatory Information for PROMETHACON
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Polymedica | PROMETHACON | promethazine hydrochloride | SUPPOSITORY;RECTAL | 084901-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Polymedica | PROMETHACON | promethazine hydrochloride | SUPPOSITORY;RECTAL | 084902-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
